Lisa Harding, MD, says ECT, ketamine, TMS, and VNS can work, but evidence on what comes after acute response remains thin.
News|Videos|January 11, 2024
Are You Attending the 2024 APSARD Conference?
Author(s)Ann Childress, MD
Ann Childress, MD, the current president of APSARD, invites you to attend this year's conference!
Advertisement
Ann Childress, MD, invites you to attend the
At this conference, you can expect:
-An update on guidelines for adult ADHD
-More information on defining the boundaries of adult ADHD
-An overview on gaps in clinical care for ADHD
-And more!
Dr Childress is president of the Center for Psychiatry and Behavior Medicine, Inc, and adjunct associate professor at the University of Nevada Las Vegas School of Medicine and Touro University Nevada College of Osteopathic Medicine.
Advertisement
Related to this article
Behind the scenes at a psychiatry conference, Gus Alva, MD, DFAPA, and Erin Crown share practical insights on burnout, industry, and emerging treatments—turning continuing education into better patient outcomes.
Review finds ADHD drugs may ease perimenopause brain fog and improve daily focus, but objective cognition gains remain unclear; larger safety and efficacy studies needed.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Ozempic Dilemma: Promises and Pitfalls in Psychiatry
2
Schizophrenia: A Telltale of the Brain’s Complexity
3
Talking With Titans: Sheldon Preskorn, MD, on the Evolution of Psychopharmacology
4
Our Continued Evolution
5